UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
Menu
Follow UroToday
  • Articles
    • Urologic Oncology
      • Adrenal Diseases
      • Biomarkers
      • Bladder Cancer
      • Bone Scintigraphy
      • Bone Targeted Treatments
      • CRPC w/ Bone Metastases
      • Immunotherapy PCa
      • mCRPC Treatment
      • Penile Cancer
      • Prostate Cancer
      • Renal Cancer
      • Testicular Cancer
      • Upper Tract Tumors
      • Investigative Urology
    • Men's Health
      • Androgen Deficiency
      • BPH
      • Erectile Dysfunction
      • Male Infertility
      • Peyronie’s Disease
      • Prostatitis
      • Vasectomy
    • Pelvic Health & Reconstruction
      • Fecal Incontinence
      • Fistula
      • GU Trauma & Reconstruction
      • Indwelling Catheters
      • Infections
      • Intermittent Catheters
      • Interstitial Cystitis
      • Neurogenic Bladder
      • Nocturia
      • Overactive Bladder
      • Pelvic Prolapse
      • Post-prostatectomy Incontinence
      • Stress Incontinence
      • Underactive Bladder
      • Urethral Strictures
      • Urinary Incontinence
      • Urinary Retention
      • Urinary Tract Infection – CAUTIs
    • Endourology & Urolithiasis
      • Minimally Invasive Procedures
      • Stone Disease
    • Pediatric Urology
      • Pediatric Urology
    • Urinary Catheters
      • History
      • Intermittent
      • Indwelling
  • Video Lectures
    • EAU 2018 GU Oncology
    • Keane's Corner
    • Advanced Prostate Cancer Consensus Conference: APCCC
    • Advanced Prostate Cancer
    • Bladder Cancer
    • Book Club
    • CRPC w/ Bone Metastases
    • Endourology
    • Hot Topic QuickTakes
    • Immunotherapy PCa
    • LUGPA GU Oncology
    • Nocturia & Lower Urinary Tract Conditions
    • M0 Prostate Cancer
    • mCRPC Treatment
    • Pelvic Health
    • Prostate Cancer
    • Radiation: Prostate Cancer
    • Urologic Catheters
  • Clinical Trials
  • Centers of Excellence
      Curated by expert editors: a single source educational forum with lectures, literature and conference information.
    • Advanced Prostate Cancer Alicia Morgans, MD, MPH
    • Bladder Cancer Ashish Kamat, MD
    • CRPC with Bone Metastases Dr. Daniel George
    • Imaging Center Phillip Koo, MD
    •  
    • mCRPC Treatment Charles Ryan, MD
    • M0 Prostate Cancer Neal Shore, MD, FACS
    • Pelvic Health Diane K. Newman, DNP, ANP-BC, FAAN
    • Lower Urinary Tract Conditions Benjamin M. Brucker, MD
    •  
  • Conference Highlights
    • APCCC
      • 2017 APCCC
    • AUA
      • 2018 Annual Meeting
      • 2017 Quality Improvement Summit
      • 2017 Annual Meeting
    • Bladder Cancer Think Tank
      • 2016 Bladder Cancer Think Tank
    • EAU
      • ESOU18
      • 2018 Annual Congress
      • 2017 Annual Congress
    • ASCO
      • 2018 ASCO GU Symposium
      • 2017 ASCO GU Symposium
      • 2017 Annual Meeting
      • 2016 Annual Meeting
    • Bladder Cancer Academy
      • 2017 Bladder Cancer Academy
    • Canadian Urological Association Meeting
      • 2017 Annual Meeting
    • ESMO
      • 2017 Annual Congress
    • LUGPA
      • 2016 Annual Meeting
    • WCE & SWL
      • 2017 Annual Meeting
      • 2016 Annual Meeting
    • SIU
      • 2017 Congress
      • 2016 Congress
    • SUFU
      • 2018 Winter Meeting
      • 2017 Winter Meeting
    • SUO
      • 2017 Annual Meeting
      • 2016 Annual Meeting
    • Targeted Alpha Therapy 10
      • TAT-10
    • IPCU
      • 2017 International Prostate Cancer Update
    • IBCN
      • 2017 International Bladder Cancer Network
  • Journals
      Print publications focusing on urological cancer treatments through original commentary & articles
    • Everyday Urology - Oncology Insights
    • Prostate Cancer and Prostatic Diseases
  • Calendar
  1. Home
  2. Recent Abstracts
  3. Pelvic Health & Reconstruction
  4. Overactive Bladder
Pelvic Health Weekly Newsletter

Overactive Bladder

Recent Abstracts
Improving Clinical Outcomes for Women with Overactive Bladder and Urinary Retention Symptoms: A Comparison of Motor Response Voltages (1 - 9) during Stage 1 Sacral Neuromodulation. April 17, 2018
Efficacy of pelvic floor muscle training in women with overactive bladder syndrome: a systematic review. April 16, 2018
THE TELOCYTES/MYOFIBROBLASTS 3-D NETWORK FORMS A STRETCH RECEPTOR IN THE HUMAN BLADDER MUCOSA. IS THIS STRUCTURE INVOLVED IN THE DETRUSOR OVERACTIVE DISEASES? April 15, 2018
Clinical features and association of bladder ultrasound findings and uroflowmetry with healing period of overactive bladder in children. April 15, 2018
Selective bladder denervation for overactive bladder (OAB) syndrome: From concept to healing outcomes using the ovine model. April 14, 2018
Clinical Efficacy of Solifenacin in the Management of Diabetes Mellitus-Associated Versus Idiopathic Overactive Bladder Symptoms: A Multicenter Prospective Study. April 10, 2018
Are the Electronic and Paper Questionnaires Equivalent in Assessing Patients with Overactive Bladder? April 10, 2018
Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder. April 1, 2018
Improvement of overactive bladder symptoms: Is correction of the paravaginal defect in anterior vaginal wall prolapse necessary? April 1, 2018
Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose? April 1, 2018
Associations Between Risk Factors and Overactive Bladder: A Meta-analysis. March 25, 2018
Coffee intake, health-related quality of life, and associated factors of overactive bladder in older Korean women living in rural South Korea. March 25, 2018
Increased risk of overactive bladder in patients with idiopathic Parkinson's disease: Insight from a nationwide population-based cohort study. March 25, 2018
Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis. March 24, 2018
Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost. March 24, 2018
Velicept Therapeutics Initiates First of Two Phase 2b Dose-Ranging Studies of Solabegron in Patients with Overactive Bladder; Finalizes Novel, Once Daily Formulation; and Receives U.S. Patent Covering OAB March 19, 2018
Vascular risk factors for male and female urgency urinary incontinence at age 68 years from a British birth cohort study. March 13, 2018
Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study. March 11, 2018
A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms. March 11, 2018
Effects of Overactive Bladder Symptoms in Stroke Patients' Health Related Quality of Life and Their Performance Scale. March 11, 2018
Page 1 of 72
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End
Pelvic Health Weekly Newsletter
  • About UroToday
  • Editorial and Advertising Guidelines
  • Editorial Leadership
  • FAQs
  • Privacy Policy
  • Terms of Use

COPYRIGHT © 2002 - 2018 DIGITAL SCIENCE PRESS, INC.

Follow UroToday

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free